Abstract
Background
In recent years, legislation targeting the sexual and gender minority (SGM) community has been passed at an increasingly alarming rate, affecting access to safe and effective gender-affirming care and forcing many SGM patients, including those with inflammatory bowel disease (IBD), to withhold their identities and health concerns. Additionally, SGM patients with IBD may have unique health considerations that have not yet been well-studied
Objective
This article aims to explore the intersection of IBD and sexual health in patients who identify as SGM and to identify limitations for gastroenterologists in caring for SGM patients. The article also aims to provide suggestions for improvement in SGM-competent care within gastroenterology
Methods
A thorough literature review was conducted regarding sexual health and the SGM community with IBD. This included a review of surgical considerations in SGM patients, sexually transmitted infections (STIs) and prevention, and sexual dysfunction
Results
Overall, little is known about the impact of IBD on patients who identify as sexual and gender minorities. Surgery, medications, and STIs continue to be a concern in the SGM community with IBD and these areas represent opportunities to improve SGM-competent IBD care. Additionally, implementation of an SGM-focused curriculum is urgently needed in medical education to improve provider knowledge and care for this unique group of patients
Conclusions
Patients with IBD who identify as SGM experience challenges that are not well described in prior literature. More research is needed and is actively being pursued to guide provider awareness and improve sexual health for this patient population.
Similar content being viewed by others
References
Perez de Arce E, Quera R, Ribeiro Barros J, Yukie Sassaki L. Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask. Int J Gen Med. 2021;14:2003–2015. https://doi.org/10.2147/IJGM.S308214.
Zhao S, Wang J, Liu Y et al. Inflammatory Bowel Diseases Were Associated with Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis. Inflamm Bowel Dis. 2019;25:699–707. https://doi.org/10.1093/ibd/izy345.
Shmidt E, Suárez-Fariñas M, Mallette M et al. A Longitudinal Study of Sexual Function in Women with Newly Diagnosed Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019;25:1262–1270. https://doi.org/10.1093/ibd/izy397.
Domislovic V, Brinar M, Cukovic-Cavka S, Turk N, Mikolasevic I, Krznaric Z. Prevalence, predictors and age-related sexual and erectile dysfunction in patients with inflammatory bowel disease: A tertiary centre experience. Int J Clin Pract. 2021;75:e14486. https://doi.org/10.1111/ijcp.14486.
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis. 2018;24:742–751. https://doi.org/10.1093/ibd/izx100.
Newman KL, Chedid VG, Boden EK. A Systematic Review of Inflammatory Bowel Disease Epidemiology and Health Outcomes in Sexual and Gender Minority Individuals. Gastroenterology. 2023;164:866–871. https://doi.org/10.1053/j.gastro.2022.11.048.
Vélez C, Casimiro I, Pitts R, Streed C, Paul S. Digestive Health in Sexual and Gender Minority Populations. Am J Gastroenterol. 2022;117:865–875. https://doi.org/10.14309/ajg.0000000000001804.
Drescher J. Out of DSM: Depathologizing Homosexuality. Behav Sci Basel Switz. 2015;5:565–575. https://doi.org/10.3390/bs5040565.
Obedin-Maliver J, Goldsmith ES, Stewart L et al. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA. 2011;306:971–977. https://doi.org/10.1001/jama.2011.1255.
CDC. STI Treatment Guidelines. Centers for Disease Control and Prevention. Published June 13, 2023. Accessed September 27, 2023. https://www.cdc.gov/std/treatment-guidelines/default.htm
Coleman E, Radix AE, Bouman WP et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgender Health. 2022;23:S1–S259. https://doi.org/10.1080/26895269.2022.2100644.
Martin T, Smukalla SM, Kane S, Hudesman DP, Greene R, Malter LB. Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review. Inflamm Bowel Dis. 2017;23:1285–1292. https://doi.org/10.1097/MIB.0000000000001186.
Wadström H, Frisell T, Sparén P, Askling J. ARTIS study group: Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden. Ann Rheum Dis. 2016;75:1272–1278. https://doi.org/10.1136/annrheumdis-2015-208263.
Kreijne JE, Goetgebuer RL, Erler NS et al. Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease. Aliment Pharmacol Ther. 2023;58:207–217. https://doi.org/10.1111/apt.17555.
Rabinowitz LG, Rabinowitz DG, Silver EM, Oxentenko AS, Williams KE, Silver JK. Disparities Persist in Inclusion of Female, Pregnant, Lactating, and Older Individuals in Inflammatory Bowel Disease Clinical Trials. Gastroenterology. 2022;163:8–13. https://doi.org/10.1053/j.gastro.2022.03.016.
Frolkis AD, Dykeman J, Negrón ME et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2013;145:996–1006. https://doi.org/10.1053/j.gastro.2013.07.041.
Dames NB, Squire SE, Devlin AB et al. “Let’s talk about sex”: a patient-led survey on sexual function after colorectal and pelvic floor surgery. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2021;23:1524–1551. https://doi.org/10.1111/codi.15598.
Dibley L, Norton C, Schaub J, Bassett P. Experiences of gay and lesbian patients with inflammatory bowel disease: a mixed methods study. Gastrointest Nurs. 2014;12:19–30. https://doi.org/10.12968/gasn.2014.12.6.19.
Castillo G, Beaty W, Miller J et al. S911 Sexual Dysfunction Improves With Biologic Therapy in Men and Women With IBD. Off J Am Coll Gastroenterol ACG. 2021;116:S430. https://doi.org/10.14309/01.ajg.0000777176.28012.0a.
Chen B, Zhou B, Song G et al. Inflammatory bowel disease is associated with worse sexual function: a systematic review and meta-analysis. Transl Androl Urol. 2022;11:959–973. https://doi.org/10.21037/tau-22-190.
Amarasekera C, Wong V, Jackson K et al. A Pilot Study Assessing Aspects of Sexual Function Predicted to Be Important After Treatment for Prostate Cancer in Gay Men: An Underserved Domain Highlighted. LGBT Health. 2020;7:271–276. https://doi.org/10.1089/lgbt.2018.0245.
Jedel S, Hood MM, Keshavarzian A. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:923–938. https://doi.org/10.1097/MIB.0000000000000257.
Marín L, Mañosa M, Garcia-Planella E et al. Sexual function and patients’ perceptions in inflammatory bowel disease: a case-control survey. J Gastroenterol. 2013;48:713–720. https://doi.org/10.1007/s00535-012-0700-2.
Fourie S, Norton C, Jackson D, Czuber-Dochan W. “These Discussions Aren’t Happening”: Experiences of People Living with Inflammatory Bowel Disease and Talking About Sexual Well-being with Health Care Professionals. J Crohns Colitis. 2021;15:1641–1648. https://doi.org/10.1093/ecco-jcc/jjab043.
Christensen B, Prentice RE, Al-Ani AH, Zhang E, Bedell A, Rubin DT. Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflamm Bowel Dis. 2022;28:1465–1468. https://doi.org/10.1093/ibd/izac025.
Acknowledgments
The authors would like to thank Garrett Lawlor, MD, for his assistance and support with this manuscript.
Funding
This is an unfunded study.
Author information
Authors and Affiliations
Contributions
AE: First draft of the manuscript, editing of the manuscript. JA: Editing of the manuscript. VC: Editing of the manuscript. SB: Editing of the manuscript. ASC: Editing of the manuscript. LGR: Drafting of the manuscript, final review of the completed manuscript.
Corresponding author
Ethics declarations
Conflict of interest
AE: No relevant conflict of interest exists. JEA: Research grants from BioFire Diagnostics and Genentech; consultancy fees, honorarium, or advisory board fees from Biomerieux, Janssen, Pfizer, BMS, Adiso, Fresenius, and Abbvie.VC: No relevant conflict of interest exists. SB: No relevant conflict of interest exists. ASC: No relevant conflict of interest exists. LGR: No relevant conflict of interest exists.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Eidelberg, A., Axelrad, J., Chedid, V. et al. Sexual Health in Sexual and Gender Minority Patients with Inflammatory Bowel Disease. Dig Dis Sci 69, 743–748 (2024). https://doi.org/10.1007/s10620-023-08253-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-023-08253-0